Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Lodhi (Manchester, United Kingdom), C. Leonard (Manchester, United Kingdom), P. Rivera Ortega (Manchester, United Kingdom), H. Morris (Manchester, United Kingdom), T. Marshall (Manchester, United Kingdom), K. Zakis (Manchester, United Kingdom), T. Garfoot (Manchester, United Kingdom), C. Hayton (Manchester, United Kingdom), M. Greaves (Manchester, United Kingdom), J. Blaikley (Manchester, United Kingdom), N. Chaudhuri (Manchester, United Kingdom). What can we learn from Idiopathic Pulmonary Fibrosis Registries?. 2195

Member's Comments

No comment yet.

Related content which might interest you: Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis? Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – M-health/e-health I Year: 2019 Epidemiology of Idiopathic Pulmonary Fibrosis in Australia Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Is Virtual Autonomous Physiotherapist Tele-rehabilitation Program feasible in Idiopathic Pulmonary Fibrosis? Source: Virtual Congress 2020 – Muscle, exercise capacity and symptoms of chronic lung disease: a physio update Year: 2020 Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Treatment of Idiopathic Pulmonary Fibrosis Source: Guideline 2015 Year: 2015 Treatment of Idiopathic Pulmonary Fibrosis - Executive Summary Source: Guideline 2015 Year: 2015 Treatment of Idiopathic Pulmonary Fibrosis - Evidence to Decision Frameworks Source: Guideline 2015 Year: 2015 The European IPF Registry: Addressing challenges and characteristics of patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Potential benefits of Nordic Walking for Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 IPF - Idiopathic Pulmonary Fibrosis Source: Breathe, 15 (2) 153; 10.1183/20734735.ELF152 Year: 2019 Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry Source: Eur Respir J , 49 (2) 1601592; DOI: 10.1183/13993003.01592-2016 Year: 2017 Idiopathic Pulmonary Fibrosis behavior in the aged population- is it different? Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 Ceremony for the ERS Idiopathic Pulmonary Fibrosis Research Award Source: International Congress 2015 – IPF: an airway-derived disease? Year: 2015 Characterize Idiopathic Pulmonary Fibrosis using Respiratory Oscillometry Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2014 – ILDs 5 Year: 2014 Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020